Many Americans caught up in the terrible cycle of addiction started with a legitimate need for and prescription for an opioid medication. But opioids come with a heavy potential cost: Your life.
We believe the best way to end the opioid abuse crisis is to stop it where it begins, the prescription pad. We need alternatives to fight pain and its causes without creating addicts.
JanOne finds and brings to market medications without the potential for abuse or misuse. We draw on the resources of the private sector, medical community and leading scientists to tackle a problem that needs new, innovative solutions and thinking.
Our commitment is to uncover medications without addictive qualities to fight disease and pain. When we have real alternatives to opioids, we help those who need it most without creating the heavy burden of potential addiction.
JanOne sees every day as an opportunity for fresh ideas to end the opioid epidemic, the worst drug crisis in our nation’s history.
As a NASDAQ-listed company, JanOne draws private-sector resources into this urgent fight. We seek innovative treatments—focusing on developing revolutionary, non-addictive drugs that kill pain, not people.
January 16, 2020
January 15, 2020
January 7, 2020
🚨JanOne is one step closer to finding a solution to non-addictive pain relief with the appointment of Dr. Christopher Kevil, Ph.D., to its scientific advisory board.
#JanOneSolution #KillPainNotPeople https://janone.com/leading-cardiovascular-researcher-and-pad-treatment-pioneer-dr-christopher-kevil-to-chair-janone-scientific-advisory-board/
💊Roughly 21 to 29% of patients prescribed #Opioids for chronic pain misuse them;
💊Between 8 and 12% develop an opioid use disorder;
➡️Learn more information on how #JanOne is working solutions to the opioid crisis: https://soo.nr/q6xn
Did you know?
• #Opioid painkillers such as oxycodone, hydrocodone & codeine have a stronger effect on women than on men?
• Women are more likely to develop an opioid addiction, and they also have a higher risk of relapse. #WomensHealth #JanOne